Haurum JS - Search Results

1

Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.

Haurum JS, Tan L, Arsequell G, Frodsham P, Lellouch AC, Moss PA, Dwek RA, McMichael AJ, Elliott T. Haurum JS, et al. Eur J Immunol. 1995 Dec;25(12):3270-6. doi: 10.1002/eji.1830251211. Eur J Immunol. 1995. PMID: 8566011

2

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes.

Haurum JS, Arsequell G, Lellouch AC, Wong SY, Dwek RA, McMichael AJ, Elliott T. Haurum JS, et al. J Exp Med. 1994 Aug 1;180(2):739-44. doi: 10.1084/jem.180.2.739. J Exp Med. 1994. PMID: 8046349 Free PMC article.

3

An improved assembly assay for peptide binding to HLA-B*2705 and H-2K(k) class I MHC molecules.

Tan L, Andersen MH, Elliott T, Haurum JS. Tan L, et al. Among authors: haurum js. J Immunol Methods. 1997 Nov 10;209(1):25-36. doi: 10.1016/s0022-1759(97)00142-7. J Immunol Methods. 1997. PMID: 9448031

4

Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo.

Haurum JS, Høier IB, Arsequell G, Neisig A, Valencia G, Zeuthen J, Neefjes J, Elliott T. Haurum JS, et al. J Exp Med. 1999 Jul 5;190(1):145-50. doi: 10.1084/jem.190.1.145. J Exp Med. 1999. PMID: 10429679 Free PMC article.

5

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.

Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ. Hill AB, et al. Among authors: haurum js. J Exp Med. 1995 Jun 1;181(6):2221-8. doi: 10.1084/jem.181.6.2221. J Exp Med. 1995. PMID: 7539044 Free PMC article.

6

Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity.

Glithero A, Tormo J, Haurum JS, Arsequell G, Valencia G, Edwards J, Springer S, Townsend A, Pao YL, Wormald M, Dwek RA, Jones EY, Elliott T. Glithero A, et al. Among authors: haurum js. Immunity. 1999 Jan;10(1):63-74. doi: 10.1016/s1074-7613(00)80007-2. Immunity. 1999. PMID: 10023771 Free article.

7

Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.

Andersen MH, Bonfill JE, Neisig A, Arsequell G, Sondergaard I, Valencia G, Neefjes J, Zeuthen J, Elliott T, Haurum JS. Andersen MH, et al. Among authors: haurum js. J Immunol. 1999 Oct 1;163(7):3812-8. J Immunol. 1999. PMID: 10490979

8

Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo.

Kastrup IB, Stevanovic S, Arsequell G, Valencia G, Zeuthen J, Rammensee HG, Elliott T, Haurum JS. Kastrup IB, et al. Among authors: haurum js. Tissue Antigens. 2000 Aug;56(2):129-35. doi: 10.1034/j.1399-0039.2000.560203.x. Tissue Antigens. 2000. PMID: 11019912

9

MHC-restricted T cell responses against posttranslationally modified peptide antigens.

Kastrup IB, Andersen MH, Elliott T, Haurum JS. Kastrup IB, et al. Among authors: haurum js. Adv Immunol. 2001;78:267-89. doi: 10.1016/s0065-2776(01)78006-6. Adv Immunol. 2001. PMID: 11432206 Review. No abstract available.

10

An assay for peptide binding to HLA-Cw*0102.

Andersen MH, Søndergaard I, Zeuthen J, Elliott T, Haurum JS. Andersen MH, et al. Among authors: haurum js. Tissue Antigens. 1999 Aug;54(2):185-90. doi: 10.1034/j.1399-0039.1999.540210.x. Tissue Antigens. 1999. PMID: 10488746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page